Both don't always report results. Academia is worse. That doesn't make the industry good in any way.
Both don't always report results. Academia is worse. That doesn't make the industry good in any way.
I'm not going to claim that industry is perfect. But take a look at the graphs. It is a picture of an industry that is generally in compliance (enforcement could perhaps be stepped up), compared to academics and government who appear to believe that compliance does not apply to them.
(Edited some typos)
I must point out that some CAR-T cell therapy is already approved. I am not sure about Juno's particular candidate, but it isn't obviously insane that it was sold for billions.
This is high stakes medicine, yet the current environment has the docs on this floor terrified of doing anything that isn’t in the standard of care runbook. My wife has had elevated blood glucose levels for six months, which is not good when you’re fighting cancer, yet i can’t get anyone to treat it because there’s no clinical evidence that managing glucose levels for her specific type of cancer has any benefit.
Guess what. Nobody’s doing that trial any time soon. Meanwhile there are thousands of diabetics managing their blood glucose while fighting cancer and there is endless material available demonstrating that cancer cells thrive in hyperglycemic environments.
So, i don’t know anything about Juno, they could be sociopaths. But i have no issues with high risk attempts as long as the patients are informed and there are ethical standards for transparency. At least they are trying.
If you're not opposed to eschewing professional recommendations to not complicate treatment, there are two things that may be worth looking into:
1). Metformin: Helps control blood glucose by significantly increasing sensitivity of insulin receptors, i.e more glucose is shuttled out of the blood stream per insulin molecule. Not scheduled and very cheap. Also trials are being done on it for cancer prevention -- exactly because of Warburg's phenomenon (cancer cells and glucose)
2). Ketosis: Hit or miss. By abstaining from carbohydrate consumption, the result should be drastically reduced blood glucose levels. However, in some people (e.g type 2 diabetics) it may elevate blood glucose due to metabolic disfunction. In any case, caloric restriction in general have the effect of both increasing insulin sensitivity and decreasing blood glucose -- regardless of macronutrient profile
There's one paper on it from a completed clinical trial. https://www.ncbi.nlm.nih.gov/pubmed/27525031?dopt=Abstract
Also clinical trials using metaformin during cancer treatment. You might consider enrolling in one of these if it is feasible.
https://www.cancer.gov/about-cancer/treatment/clinical-trial...
I tried going the A1C route to justify intervention but anemia and transfusions both push A1C low. I also just got a prescription for a Freestyle Libre to monitor blood glucose.
We’ve never got quite to the level of ketogenic but have tried focusing on fats and proteins for calories and keeping carbs between 50-100/day.